H.C. Wainwright Starts Biodesix (BDSX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts BDSX Hot Sheet
Price: $21.05 --0%
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 11
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 11
Join SI Premium – FREE
H.C. Wainwright analyst Yi Chen initiates coverage on Biodesix (NASDAQ: BDSX) with a Buy rating and a price target of $26.00.
For an analyst ratings summary and ratings history on Biodesix click here. For more ratings news on Biodesix click here.
Shares of Biodesix closed at $15.06 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Starts Insmed (INSM) at Buy
- Duolingo Inc. (DUOL) PT Raised to $145 at Morgan Stanley
- Arista Networks (ANET) PT Raised to $230 at Morgan Stanley
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, H.C. Wainwright, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
